Exact Sciences Cancerguard Liquid Biopsy Test SEO Title
FOR IMMEDIATE RELEASE
Exact Sciences Launches Cancerguard, a Revolutionary Liquid Biopsy Test for Early Cancer Detection
Madison, WI – In a landmark move poised to redefine cancer screening, Exact Sciences has launched Cancerguard, a cutting-edge liquid biopsy test designed to detect signals for 50 different types of cancer. This innovative test is now available to consumers, marking a meaningful leap forward in early cancer detection.
“I am feeling fantastic. This is what I came to Exact to do,” exclaimed Dr. Tom Beer, chief medical officer of Exact Sciences and a practicing oncologist. Dr. Beer emphasized the profound impact of early cancer detection, a reality he witnesses weekly in his clinic. Cancerguard aims to extend this advantage to a broader range of cancers beyond the currently screened breast,prostate,colorectal,lung,and cervical cancers.
Cancerguard represents a paradigm shift in cancer screening. By analyzing a simple blood sample, the test can identify potential cancer signals, offering individuals and their healthcare providers a crucial head start in diagnosis and treatment.
“we are introducing a test, but we are really starting a new era in cancer early detection,” Dr. Beer stated. He envisions a future where screening for a multitude of cancers becomes the norm, a stark contrast to the limited screening practices of today. “It’s early days, but I think in 10 years, when we look back on today, we won’t believe we used to only screen for a handful of cancers.”
about Exact Sciences
Exact Sciences is a leading biotechnology company focused on developing innovative cancer screening and diagnostic tests. With a commitment to early detection, Exact Sciences aims to improve patient outcomes and transform the fight against cancer.
Contact:
[Insert contact Name]
[Insert Title]
[Insert email]
[Insert Phone Number]
###